We are working to pioneer the path of tomorrow’s medicine. Material intended for medical class. September 2024. Powerful portfolio in multiple myeloma. For all patients, at all stages of their journey. For more information, please contact us. INFORME CORPORATIVO O conteúdo deste informe é de inteira responsabilidade da empresa e não representa necessariamente a opinião da ABHH.
RkJQdWJsaXNoZXIy MTg4NjE0Nw==